|
| Andhra Pradesh ~ India ~ International ~ City ~ Entertainment ~ Business ~ Bullion ~ Forex ~ Sports ~ Technology ~ Health ~ Features |
| Lung Cancer ~ Lung Cancer ~ Breast Cancer ~ Heart attack ~ All Health Topics |
|
Home
/ Health News / 2007 / September 2007 / September 25, 2007 Ancient snakebite treatment may harbour cure for HIV |
Structure of key breast cancer target enzyme unraveled
A researcher at Hauptman-Woodward Medical Research Institute has moved a step closer to a cure, and possibly the prevention, of the most common type of breast cancer. ANI
Smoking claimed 673,000 Chinese lives in 2005
A multinational research team, led by scientists at Tulane University School of Public Health and Tropical Medicine, has lent more force to the suggestion that smoking is a significant risk factor for mortality and disease. ANI
Genetic mutations can predict childhood leukaemia relapse
A collaborative study by American researchers has revealed that changes in a gene called IKAROS can help predict a high likelihood of relapse in children with acute lymphoblastic leukaemia (ALL). ANI
Scientists from Australia, Europe and the US have found that a Chinese herb, which has been used to treat snakebites and boils for centuries, has the potential to fight HIV/AIDS.
Sydney, September 25 : Scientists from Australia, Europe and the US have found that a Chinese herb, which has been used to treat snakebites and boils for centuries, has the potential to fight HIV/AIDS.
The researchers say that an Asian violet known as Viola yedoensis contains tiny proteins that appear to kill off infected cells. Such anti-HIV and anti-bacterial qualities, say the researchers, make the plant a target for new drug therapies to treat the HIV virus.
While presenting their findings at COMBIO 2007, a meeting of biochemistry and molecular biology specialists in Sydney, researchers at the University of Queensland said that the plant contains small proteins called cyclotides that might act as defensive agents.
The researchers tested the ability of the cyclotides by applying them to two sets of cells-one infected with HIV and the other virus-free. Their aim was to see how many of the cells infected with HIV were destroyed after the application of the cyclotides.
"The results were encouraging. The actions of the cyclotides are yet not fully understood and the research is at a very early stage," said new.com.au quoted Professor David Craik from the Institute for Molecular Bioscience at the University of Queensland as saying.
''(But) it may be that we can use the lessons of nature to create synthetic drug designs to help people with the virus,'' he added.
Researchers at the National Cancer Institute in the US and the Division of Pharmacology at Uppsala University in Sweden also collaborated on the study.
ANI
